Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4868598
Max Phase: Preclinical
Molecular Formula: C18H22N2O6
Molecular Weight: 362.38
Molecule Type: Unknown
Associated Items:
ID: ALA4868598
Max Phase: Preclinical
Molecular Formula: C18H22N2O6
Molecular Weight: 362.38
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)c1ccc2c(c1)nc(CO[C@@H]1C=CO[C@H](CO)[C@@H]1O)n2C
Standard InChI: InChI=1S/C18H22N2O6/c1-3-24-18(23)11-4-5-13-12(8-11)19-16(20(13)2)10-26-14-6-7-25-15(9-21)17(14)22/h4-8,14-15,17,21-22H,3,9-10H2,1-2H3/t14-,15-,17-/m1/s1
Standard InChI Key: VSHSIOZVAMTVGW-BFYDXBDKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 362.38 | Molecular Weight (Monoisotopic): 362.1478 | AlogP: 0.90 | #Rotatable Bonds: 6 |
Polar Surface Area: 103.04 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.05 | CX Basic pKa: 3.19 | CX LogP: 0.67 | CX LogD: 0.67 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.74 | Np Likeness Score: 0.03 |
1. Hassan M, Baussière F, Guzelj S, Sundin AP, Håkansson M, Kovačič R, Leffler H, Tomašič T, Anderluh M, Jakopin Ž, Nilsson UJ.. (2021) Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain., 12 (11.0): [PMID:34795863] [10.1021/acsmedchemlett.1c00371] |
Source(1):